{"id":29273,"date":"2025-11-10T04:32:00","date_gmt":"2025-11-09T20:32:00","guid":{"rendered":"https:\/\/csccm.org.cn\/?p=29273"},"modified":"2025-11-10T05:43:48","modified_gmt":"2025-11-09T21:43:48","slug":"lancet-respir-med%e5%8f%91%e8%a1%a8%e8%ae%ba%e6%96%87%ef%bc%9a%e7%be%8e%e5%9b%bd%e5%84%bf%e7%ab%a5%e5%92%8c%e9%9d%92%e5%b0%91%e5%b9%b4%e7%9a%84%e6%80%a5%e6%80%a7%e8%82%ba%e6%a0%93%e5%a1%9e","status":"publish","type":"post","link":"https:\/\/csccm.org.cn\/?p=29273","title":{"rendered":"[Lancet Respir Med\u53d1\u8868\u8bba\u6587]\uff1a\u7f8e\u56fd\u513f\u7ae5\u548c\u9752\u5c11\u5e74\u7684\u6025\u6027\u80ba\u6813\u585e"},"content":{"rendered":"\n<p>Articles<\/p>\n\n\n\n<h1 class=\"wp-block-heading\" id=\"screen-reader-main-title\">Acute pulmonary embolism in children and adolescents in the USA (2016 and 2019): a nationwide retrospective cohort study<\/h1>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"screen-reader-main-title\">Simon\u00a0Wolf,\u00a0Luca\u00a0Valerio,\u00a0Nils\u00a0Kucher, et al<\/h3>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"screen-reader-main-title\">Lancet Respir Med 2025; 13: 393-402<\/h3>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"screen-reader-main-title\">https:\/\/doi.org\/10.1016\/S2213-2600(24)00412-0<\/h3>\n\n\n\n<h2 class=\"wp-block-heading\">Summary<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"cestitle20\">Background<\/h3>\n\n\n\n<p>Epidemiological data on acute&nbsp;<a href=\"https:\/\/www.sciencedirect.com\/topics\/medicine-and-dentistry\/pulmonary-embolism\">pulmonary embolism<\/a>&nbsp;among children and adolescents are sparse and only date back to the 2000s. We aimed to establish annual estimates and age-stratified and sex-stratified indicators of acute&nbsp;<a href=\"https:\/\/www.sciencedirect.com\/topics\/pharmacology-toxicology-and-pharmaceutical-science\/lung-embolism\">pulmonary embolism<\/a>&nbsp;among children and adolescents aged 0\u201319 years.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"cestitle30\">Methods<\/h3>\n\n\n\n<p>We did a retrospective, nationwide, patient-level analysis of the Kids\u2019 Inpatient Database, including 5733 patients with&nbsp;<a href=\"https:\/\/www.sciencedirect.com\/topics\/medicine-and-dentistry\/acute-pulmonary-embolism\">acute pulmonary embolism<\/a>&nbsp;aged 0\u201319 years admitted to hospital in the USA in 2016 and 2019. The database includes data of all children admitted to hospital during the 2 years available. We also accessed the US Multiple Cause of Death database and population data from the US Census Bureau for the same 2 years. We estimated the incidence, mortality,&nbsp;<a href=\"https:\/\/www.sciencedirect.com\/topics\/pharmacology-toxicology-and-pharmaceutical-science\/case-fatality-rate\">case fatality<\/a>, and proportional&nbsp;<a href=\"https:\/\/www.sciencedirect.com\/topics\/pharmacology-toxicology-and-pharmaceutical-science\/mortality-rate\">mortality rates<\/a>, provided data on the annual pulmonary embolism burden, and provided data on clinical events recorded during hospitalisation.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"cestitle40\">Findings<\/h3>\n\n\n\n<p>In the years 2016 and 2019, 5733 patients (3353 [58.5%] female and 2380 [41.5%] male) were admitted to hospital with acute pulmonary embolism as the primary diagnosis or a concomitant diagnosis. The annual incidence of acute pulmonary embolism was 3\u00b75 (95% CI 3\u00b74\u20133\u00b76) per 100 000 people. Two peaks in the incidence rate were observed\u2014one in infants younger than 1 year and one in adolescents aged 15\u201319 years. The in-hospital\u00a0<a href=\"https:\/\/www.sciencedirect.com\/topics\/medicine-and-dentistry\/case-fatality-rate\">case fatality<\/a>\u00a0rate was 4\u00b75% (4\u00b70\u20135\u00b71). The crude odds ratio for in-hospital death among patients with (<em>vs<\/em>\u00a0without) acute pulmonary embolism was 9\u00b73 (7\u00b79\u201310\u00b79). The association between acute pulmonary embolism and death persisted across different multivariable models. Patients with acute pulmonary embolism with high-risk (<em>vs<\/em>\u00a0no high-risk) features had the highest risk of death: 25\u00b73% (20\u00b76\u201330\u00b75) among patients aged 0\u20139 years and 13\u00b79% (11\u00b79\u201316\u00b72) among patients aged 10\u201319 years. In patients without high-risk features, risk of death was 4\u00b79% (3\u00b71\u20137\u00b76) among patients aged 0\u20139 years and 0\u00b77% (0\u00b75\u20131\u00b70) among patients aged 10\u201319 years. The risk of\u00a0<a href=\"https:\/\/www.sciencedirect.com\/topics\/pharmacology-toxicology-and-pharmaceutical-science\/brain-hemorrhage\">intracranial bleeding<\/a>\u00a0was also highest in the presence of pulmonary embolism with high-risk features: 8\u00b71% (5\u00b75\u201311\u00b77) among patients aged 0\u20139 years and 3\u00b76% (2\u00b76\u20134\u00b79) among patients aged 10\u201319 years. In patients without high-risk features, the risk of\u00a0<a href=\"https:\/\/www.sciencedirect.com\/topics\/medicine-and-dentistry\/cerebral-hemorrhage\">intracranial bleeding<\/a>\u00a0was 2\u00b75% (1\u00b73\u20134\u00b76) among those aged 0\u20139 years and 0\u00b75% (0\u00b73\u20130\u00b78) in those aged 10\u201319 years. Reperfusion treatments beyond systemic\u00a0<a href=\"https:\/\/www.sciencedirect.com\/topics\/medicine-and-dentistry\/blood-clot-lysis\">thrombolysis<\/a>\u00a0were rarely used among children and adolescents with acute pulmonary embolism.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/ars.els-cdn.com\/content\/image\/1-s2.0-S2213260024004120-gr1_lrg.jpg\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/ars.els-cdn.com\/content\/image\/1-s2.0-S2213260024004120-gr2_lrg.jpg\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/ars.els-cdn.com\/content\/image\/1-s2.0-S2213260024004120-gr3_lrg.jpg\" alt=\"\"\/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"cestitle50\">Interpretation<\/h3>\n\n\n\n<p>Acute pulmonary embolism is rare during childhood and adolescence. The high pulmonary embolism-related fatality among specific subgroups of patients can be interpreted in the context of severe comorbidities and pulmonary embolism events with high-risk features.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"cestitle60\">Funding<\/h3>\n\n\n\n<p>None.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Articles Acute pulmonary embolism in children and adole [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[32,23],"tags":[],"_links":{"self":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/29273"}],"collection":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=29273"}],"version-history":[{"count":1,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/29273\/revisions"}],"predecessor-version":[{"id":29274,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/29273\/revisions\/29274"}],"wp:attachment":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=29273"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=29273"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=29273"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}